Cargando…
Yes-associated protein inhibition ameliorates liver fibrosis and acute and chronic liver failure by decreasing ferroptosis and necroptosis
BACKGROUND/AIMS: This study aims to determine which cell death modes contribute most in the progression of cirrhosis and acute-on-chronic liver failure (ACLF), and to investigate whether Yes associated protein (YAP) affects the disease process by regulating cell death. MATERIALS AND METHODS: 30C57BL...
Autores principales: | Zhao, Wen, Lei, Miao, Li, Jinfeng, Zhang, Hailin, Zhang, Hongkun, Han, Yuxin, Ba, Zhiwei, Zhang, Manli, Li, Dongdong, Liu, Chuanmiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161368/ https://www.ncbi.nlm.nih.gov/pubmed/37151632 http://dx.doi.org/10.1016/j.heliyon.2023.e15075 |
Ejemplares similares
-
Doxofylline ameliorates liver fibrosis by regulating the ferroptosis signaling pathway
por: Xu, Lenan, et al.
Publicado: (2023) -
Loss of MLKL ameliorates liver fibrosis by inhibiting hepatocyte necroptosis and hepatic stellate cell activation
por: Guo, Ren, et al.
Publicado: (2022) -
Ferroptosis and Liver Fibrosis
por: Pan, Qi, et al.
Publicado: (2021) -
Necroptosis contributes to chronic inflammation and fibrosis in aging liver
por: Mohammed, Sabira, et al.
Publicado: (2021) -
Ferroptosis, necroptosis, and pyroptosis in anticancer immunity
por: Tang, Rong, et al.
Publicado: (2020)